T-type and L-type calcium channel blockers for the treatment of cardiac iron overload: An update
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved. In patients with thalassemia, iron overload cardiomyopathy is a major cause of cardiac dysfunction and mortality. Despite many advances in the development of new iron chelating agents, heart failure still occurs in some patients and c...
Saved in:
Main Authors: | Sirinart Kumfu, Siriporn C. Chattipakorn, Nipon Chattipakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85045564707&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/57792 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice
by: Juthamas Khamseekaew, et al.
Published: (2018) -
Combined iron chelator and T-type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice
by: Sirinart Kumfu, et al.
Published: (2018) -
Combined iron chelator and T-type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice
by: Sirinart Kumfu, et al.
Published: (2019) -
Combined iron chelator with N-acetylcysteine exerts the greatest effect on improving cardiac calcium homeostasis in iron-overloaded thalassemic mice
by: Natticha Sumneang, et al.
Published: (2020) -
Current and future treatment strategies for iron overload cardiomyopathy
by: Suwakon Wongjaikam, et al.
Published: (2018)